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Introduction
Delirium is frequent in the critically ill and is associated
with long-term morbidity [1]. Currently, the key approach
for delirium in the ICU is avoidance of risk factors. Systemic
corticosteroids are often used in the ICU, and regularly
administered in high dosages, as increasing evidence sug-
gests potential benefits of these medications in critically ill
patients [2,3]. However, corticosteroids are proposed to be a
risk factor delirium in patients with acute lung injury [4].
Objective
To investigate whether systemic corticosteroids increase
the probability of transitioning to delirium in a mixed
medical-surgical ICU population.
Methods
We conducted a prospective cohort study in a 32bed
mixed medical-surgical ICU. Critically ill adults who
stayed in the ICU for more than 24hours, without acute
neurological disorders or other conditions hampering
delirium assessment were included. Systemic corticoster-
oid administration was measured daily. Dosage were con-
verted in milligrams (mg) prednisone equivalents. Daily
mental status was classified as ‘coma’, ‘delirium’, or an
‘awake without delirium’ state using a previously described
algorithm based on the CAM-ICU score [5]. The primary
outcome, daily transition from an ‘awake without delirium’
state to ‘delirium’ was analyzed using a first order Markov
multinomial logistic regression model, taking competing
events such as discharge and death into account.
Results
A total of 1112 patients accounted for 9867 ICU days. The
transition from being ‘awake without delirium’ to ‘delirium’
occurred 562 times (6%). On 3483 days (35%) systemic cor-
ticosteroids were administered, with a median dosage of 50
(interquartile range 25-75) mg prednisone equivalents.
Administration of systemic corticosteroids was not signifi-
cantly associated with the transition to delirium (adjusted
odds ratio 1.08, 95%CI 0.89-1.32). Increasing dosage on
days patients received corticosteroids was not associated
with an increased odds of transitioning to delirium either
(adjusted odds ratio 1.00, 95%CI 0.99-1.01, per 10 mg
increase in prednisone equivalents).
Conclusions
Our findings suggest that exposure to systemic corticos-
teroids is not a risk factor for the transition to delirium.
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